RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
RadNet, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$69.27+0.47 (+0.68%)
Close on Oct 19, 2026
- Market cap
- $5.45B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.66 (−9.96%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
RadNet, Inc. grew revenue 18.9% to $2.27B over the twelve months to Jun 30, 2026. Operating income rose 8.5% to $70.78M, moving the operating margin from 3.4% to 3.1%.
Revenue
$2.27B
+18.9% vs. a year earlier
Operating income
$70.78M
+8.5% vs. a year earlier
EPS, diluted
-$0.27
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.45B
- P/E ratio
- –
- Price to sales
- 2.40
- Price to book
- 4.98
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.27B
- Net income
- -$21.12M
- EPS, diluted
- -$0.27
- Book value per share
- $13.92
- Diluted shares
- 79M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$2.27B+18.9% YoY
Gross profit
–
Operating income
$70.78M+8.5% YoY
Net income
-$21.12M
EPS, diluted
-$0.27
Free cash flow
–
Reported periodTrailing twelve months